AKT1 and liver dysplastic nodule: Autophagy is an important therapeutic target for DN; studies have shown that geniposide can increase MAPK activity in DN mice, enhance ULK1-mediated autophagy response, reduce AKT activity, thereby blocking oxidative stress, phlegmonosis, and renal fibrosis in diabetic kidneys (Dusabimana et al., 2021).